This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Reviewing the FDA approval of Abbott's AVEIR system, the first Dual Chamber Leadless Pacemaker

Ticker(s): ABT, MDT, BSX, BIOTRONIK

Who's the expert?

Institution: Northwestern University

  • Director of Cardiac Electrophysiology at Northwestern Medicine and the Director of the Heart Rhythm Center at the Bluhm Cardiovascular Institute. 
  • Implants 4 pacemakers a month.
  • Research interest in evaluating novel ablation tools and implantable devices, including the cryoballoon for pulmonary vein isolation, the totally subcutaneous implantable defibrillator, and left atrial appendage occlusion devices.
  • Coauthored over 300 scientific papers and is on the editorial board of several high-impact medical journals.

Interview Questions
Q1.

Describe your background and practice setting

Added By: ben_admin
Q2.

How many patients with heart arrhythmia issues do you currently manage?

Added By: ben_admin
Q3.

Which patients are candidates for a pacemaker?

Added By: ben_admin
Q4.

What is your opinion of the AVEIR pacemaker system?

Added By: ben_admin
Q5.

What % of your pacemaker cases will you utilize the Aveir system?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.